Modeling Drug Disposition and Drug-Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective
- PMID: 29204788
- DOI: 10.1007/s13318-017-0452-8
Modeling Drug Disposition and Drug-Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective
Comment on
-
Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam.Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):355-367. doi: 10.1007/s13318-017-0447-5. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29119333 Free PMC article.
Similar articles
-
Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.Curr Opin Drug Discov Devel. 2009 Jul;12(4):509-18. Curr Opin Drug Discov Devel. 2009. PMID: 19562647 Review.
-
[Dynamic Simulation of Drug-Drug Interactions by Using Multi-level Physiological Modeling & Simulation Platforms].Yakugaku Zasshi. 2018;138(3):347-351. doi: 10.1248/yakushi.17-00191-2. Yakugaku Zasshi. 2018. PMID: 29503427 Japanese.
-
In silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond.Adv Drug Deliv Rev. 2015 Jun 23;86:46-60. doi: 10.1016/j.addr.2015.03.006. Epub 2015 Mar 19. Adv Drug Deliv Rev. 2015. PMID: 25796619 Review.
-
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.Eur J Pharm Sci. 2013 Aug 16;49(5):819-28. doi: 10.1016/j.ejps.2013.06.009. Epub 2013 Jun 24. Eur J Pharm Sci. 2013. PMID: 23806476
-
The role of physiologically based pharmacokinetic modeling in regulatory review.Clin Pharmacol Ther. 2012 Mar;91(3):542-9. doi: 10.1038/clpt.2011.320. Epub 2012 Feb 8. Clin Pharmacol Ther. 2012. PMID: 22318616
Cited by
-
Model-Informed Approaches for Alternative Aripiprazole Dosing Regimens and Missed Dose Management: Towards Better Adherence to Antipsychotic Pharmacotherapy.Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):471-473. doi: 10.1007/s13318-018-0494-6. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29946921 No abstract available.
-
Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.Eur J Clin Pharmacol. 2019 Apr;75(4):543-551. doi: 10.1007/s00228-018-02610-z. Epub 2018 Dec 19. Eur J Clin Pharmacol. 2019. PMID: 30569284
-
Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.Clin Pharmacokinet. 2019 Jul;58(7):927-941. doi: 10.1007/s40262-019-00737-5. Clin Pharmacokinet. 2019. PMID: 30767128
-
Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers.Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):691-711. doi: 10.1007/s13318-019-00559-7. Eur J Drug Metab Pharmacokinet. 2019. PMID: 31114948
-
Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.Eur J Drug Metab Pharmacokinet. 2020 Feb;45(1):151-156. doi: 10.1007/s13318-019-00587-3. Eur J Drug Metab Pharmacokinet. 2020. PMID: 31691904 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources